A One Stop Shop for Everything Futures Trading
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.

FNCH Insider Trading (Finch Therapeutics Group)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $649,993.00
Insider Selling (Last 12 Months): $0.00

Finch Therapeutics Group Insider Trading History Chart

This chart shows the insider buying and selling history at Finch Therapeutics Group by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Finch Therapeutics Group Share Price & Price History

Current Price: $2.83
Price Change: Price Decrease of -0.01 (-0.35%)
As of 07/1/2022 04:59 PM ET

This chart shows the closing price history over time for FNCH up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Protect Your Trading Account With Options!
This might be the opposite of what you’ve heard, but the real risk in the market now lies with stock trading… “Options Trading Made Easy” by expert Chuck Hughes will show you how the nature of options trading gives you the chance to profit no matter which way the market trends!

Get the e-book today!
>>>

Finch Therapeutics Group Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/20/2021Nicholas HaftDirectorBuy63,850$10.18$649,993.00View SEC Filing Icon  
3/23/2021Jeffery A. SmisekDirectorBuy88,235$17.00$1,499,995.00View SEC Filing Icon  
See Full Table
Trading Isn’t Getting Easier–But Options Just Did!
Options trading expert and trading champion Chuck Hughes has done it again with his guide, “Options Trading Made Easy”!

Made for new traders, this guide explains options–plus the consistent profits you could make–in easy to understand terms.

Don’t keep waiting for it to get easier–get the e-book here!
>>>

SEC Filings (Institutional Ownership Changes) for Finch Therapeutics Group (NASDAQ:FNCH)

22.68% of Finch Therapeutics Group stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at FNCH by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Finch Therapeutics Group Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
6/7/2022Bank of America Corp DE5,486$27K0.0%-61.8%0.012%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC45,000$0.23M0.0%+19.4%0.095%Search for SEC Filing on Google Icon
5/13/2022Baupost Group LLC MA1,123,108$5.65M0.1%-0.8%2.363%Search for SEC Filing on Google Icon
5/13/2022Ergoteles LLC19,002$96K0.0%-70.3%0.040%Search for SEC Filing on Google Icon
5/12/2022BlackRock Inc.404,931$2.04M0.0%+2.3%0.852%Search for SEC Filing on Google Icon
5/9/2022Qube Research & Technologies Ltd37,631$0.19M0.0%+53.6%0.079%Search for SEC Filing on Google Icon
2/16/2022Lake Street Advisors Group LLC739,136$7.37M0.5%+16.2%1.557%Search for SEC Filing on Google Icon
2/15/2022Light Street Capital Management LLC811,731$8.09M0.5%+1.8%1.710%Search for SEC Filing on Google Icon
2/14/2022SCS Capital Management LLC38,294$0.38M0.0%N/A0.081%Search for SEC Filing on Google Icon
2/14/2022Avenir Management Company LLC1,663,366$16.58M8.9%N/A3.503%Search for SEC Filing on Google Icon
2/11/2022Baupost Group LLC MA1,132,253$11.29M0.1%-6.3%2.385%Search for SEC Filing on Google Icon
2/10/2022Qube Research & Technologies Ltd24,503$0.24M0.0%N/A0.052%Search for SEC Filing on Google Icon
2/8/2022Northern Trust Corp67,445$0.67M0.0%-2.7%0.142%Search for SEC Filing on Google Icon
2/1/2022Qube Research & Technologies Ltd24,503$0.24M0.0%N/A0.052%Search for SEC Filing on Google Icon
11/16/2021Laurion Capital Management LP58,000$0.75M0.0%-3.3%0.122%Search for SEC Filing on Google Icon
11/16/2021MSD Partners L.P.388,691$5.05M0.3%+65.2%0.819%Search for SEC Filing on Google Icon
11/15/2021Ancora Advisors LLC6,946$90K0.0%+73.7%0.015%Search for SEC Filing on Google Icon
11/15/2021Lake Street Advisors Group LLC636,195$8.27M0.9%N/A1.341%Search for SEC Filing on Google Icon
11/15/2021Proficio Capital Partners LLC110,559$1.44M0.2%-1.3%0.233%Search for SEC Filing on Google Icon
11/15/2021HighTower Advisors LLC18,099$0.24M0.0%+21.6%0.038%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC153,549$2M0.0%+9.3%0.324%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.387,339$5.04M0.0%+2.9%0.816%Search for SEC Filing on Google Icon
11/8/2021TRB Advisors LP570,000$7.41M2.7%+3.6%1.201%Search for SEC Filing on Google Icon
10/27/2021Ballentine Partners LLC143,603$1.87M0.1%N/A0.303%Search for SEC Filing on Google Icon
10/12/2021First Midwest Bank Trust Division26,344$0.34M0.0%N/A0.056%Search for SEC Filing on Google Icon
8/18/2021Ikarian Capital LLC325,000$4.57M0.4%+116.7%0.685%Search for SEC Filing on Google Icon
8/17/2021Woodline Partners LP53,371$0.75M0.0%-55.3%0.112%Search for SEC Filing on Google Icon
8/17/2021Light Street Capital Management LLC168,330$2.37M0.1%N/A0.355%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC65,141$0.92M0.0%-68.4%0.137%Search for SEC Filing on Google Icon
8/17/2021MSD Partners L.P.235,294$3.31M0.2%-39.5%0.496%Search for SEC Filing on Google Icon
8/17/2021Boothbay Fund Management LLC35,550$0.50M0.0%+102.2%0.075%Search for SEC Filing on Google Icon
8/16/2021California State Teachers Retirement System10,464$0.15M0.0%N/A0.022%Search for SEC Filing on Google Icon
8/16/2021Pinz Capital Management LP3,170$45K0.0%-87.3%0.007%Search for SEC Filing on Google Icon
8/16/2021Charles Schwab Investment Management Inc.49,376$0.70M0.0%N/A0.104%Search for SEC Filing on Google Icon
8/16/2021State Street Corp71,018$1M0.0%N/A0.150%Search for SEC Filing on Google Icon
8/16/2021Nuveen Asset Management LLC12,002$0.17M0.0%N/A0.025%Search for SEC Filing on Google Icon
8/13/2021Steward Partners Investment Advisory LLC2,250$32K0.0%N/A0.005%Search for SEC Filing on Google Icon
8/13/2021Ancora Advisors LLC4,000$56K0.0%N/A0.008%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp76,058$1.07M0.0%N/A0.160%Search for SEC Filing on Google Icon
8/13/2021Laurion Capital Management LP60,000$0.84M0.0%-3.2%0.126%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC140,521$1.98M0.0%N/A0.296%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.174,795$2.46M0.0%+399.4%0.369%Search for SEC Filing on Google Icon
8/12/2021JPMorgan Chase & Co.10,021$0.14M0.0%N/A0.021%Search for SEC Filing on Google Icon
8/11/2021Bank of New York Mellon Corp15,325$0.22M0.0%N/A0.032%Search for SEC Filing on Google Icon
8/11/2021BlackRock Inc.376,444$5.30M0.0%+141.8%0.794%Search for SEC Filing on Google Icon
8/11/2021Deutsche Bank AG4,492$63K0.0%N/A0.009%Search for SEC Filing on Google Icon
8/6/2021HighTower Advisors LLC14,888$0.21M0.0%+32.7%0.031%Search for SEC Filing on Google Icon
8/2/2021New York State Common Retirement Fund6,500$91K0.0%N/A0.014%Search for SEC Filing on Google Icon
6/3/2021Bleichroeder LP810,416$13.09M2.2%N/A1.709%Search for SEC Filing on Google Icon
5/25/2021Aperture Investors LLC469,584$7.47M1.1%N/A0.990%Search for SEC Filing on Google Icon
5/19/2021Blackstone Group Inc.125,000$2.02M0.0%N/A0.264%Search for SEC Filing on Google Icon
5/19/2021Squarepoint Ops LLC30,000$0.49M0.0%N/A0.063%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC206,297$3.28M0.0%N/A0.435%Search for SEC Filing on Google Icon
5/18/2021Tudor Investment Corp Et Al17,259$0.28M0.0%N/A0.037%Search for SEC Filing on Google Icon
5/18/2021Blackstone Group Inc.125,000$2.02M0.0%N/A0.265%Search for SEC Filing on Google Icon
5/18/2021Alyeska Investment Group L.P.39,700$0.64M0.0%N/A0.084%Search for SEC Filing on Google Icon
5/18/2021MSD Partners L.P.388,691$6.28M0.4%N/A0.824%Search for SEC Filing on Google Icon
5/17/2021Point72 Hong Kong Ltd14,827$0.24M0.0%N/A0.031%Search for SEC Filing on Google Icon
5/17/2021Woodline Partners LP119,334$1.93M0.0%N/A0.253%Search for SEC Filing on Google Icon
5/17/2021Captrust Financial Advisors3,175$51K0.0%N/A0.007%Search for SEC Filing on Google Icon
5/17/2021Caas Capital Management LP20,000$0.32M0.0%N/A0.042%Search for SEC Filing on Google Icon
5/17/2021Pinz Capital Management LP24,900$0.40M0.1%N/A0.053%Search for SEC Filing on Google Icon
5/17/2021Sphera Funds Management LTD.150,000$2.39M0.2%N/A0.318%Search for SEC Filing on Google Icon
5/17/2021Ikarian Capital LLC150,000$2.39M0.1%N/A0.318%Search for SEC Filing on Google Icon
5/17/2021Goldman Sachs Group Inc.59,124$0.96M0.0%N/A0.125%Search for SEC Filing on Google Icon
5/14/2021Baupost Group LLC MA1,208,159$18.87M0.2%N/A2.563%Search for SEC Filing on Google Icon
5/14/2021Laurion Capital Management LP62,000$0.99M0.0%N/A0.132%Search for SEC Filing on Google Icon
5/14/2021Monashee Investment Management LLC125,000$2.02M0.3%N/A0.265%Search for SEC Filing on Google Icon
5/14/2021Sectoral Asset Management Inc390,000$6.30M0.5%N/A0.827%Search for SEC Filing on Google Icon
5/12/2021Pura Vida Investments LLC160,000$2.58M0.1%N/A0.339%Search for SEC Filing on Google Icon
5/12/2021TRB Advisors LP550,000$8.75M3.4%N/A1.167%Search for SEC Filing on Google Icon
5/10/2021HighTower Advisors LLC11,218$0.18M0.0%N/A0.024%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.155,657$2.52M0.0%N/A0.330%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Finch Therapeutics Group logo
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides difficile infection, as well as for the treatment of chronic hepatitis B virus. It is also developing FIN-211, an orally administered enriched consortia product candidate for use in the treatment of autism spectrum disorder; and TAK-524 and FIN-525, which are orally administered targeted consortia product candidates for the treatment of ulcerative colitis and Crohn's disease. The company has collaboration and license agreements with Takeda Pharmaceutical Company Limited; Skysong Innovations LLC; and University of Minnesota. Finch Therapeutics Group, Inc. was incorporated in 2014 and is based in Somerville, Massachusetts.
Read More on Finch Therapeutics Group

Today's Range

Now: $2.83
Low: $2.80
High: $2.94

50 Day Range

MA: $2.44
Low: $1.91
High: $2.84

52 Week Range

Now: $2.83
Low: $1.71
High: $17.39

Volume

1,107 shs

Average Volume

518,761 shs

Market Capitalization

$134.59 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Finch Therapeutics Group?

Finch Therapeutics Group's top insider investors include:
  1. Jeffery A Smisek (Director)
  2. Nicholas Haft (Director)
Learn More about top insider investors at Finch Therapeutics Group.
Better Options For Trading!
I know–you’ve heard options trading is tough, but is it really tougher than the market is right now?

NO! “Options Trading Made Easy” by pro-trader Chuck Hughes gives traders the best options in an unpredictable market…

Get your copy now!
>>>